LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,089,765 | -23.7% | 18,187 | -8.2% | 0.00% | 0.0% |
| Q2 2023 | $1,429,094 | -5.1% | 19,821 | -3.1% | 0.00% | 0.0% |
| Q1 2023 | $1,505,258 | +8.7% | 20,463 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $1,384,564 | -21.5% | 20,727 | +1.2% | 0.00% | -33.3% |
| Q3 2022 | $1,764,000 | -4.7% | 20,481 | -1.3% | 0.00% | 0.0% |
| Q2 2022 | $1,851,000 | -20.1% | 20,749 | +0.7% | 0.00% | 0.0% |
| Q1 2022 | $2,318,000 | -32.7% | 20,604 | -7.6% | 0.00% | -25.0% |
| Q4 2021 | $3,445,000 | +13.4% | 22,305 | +2.3% | 0.00% | 0.0% |
| Q3 2021 | $3,037,000 | +11.3% | 21,796 | +4.8% | 0.00% | +33.3% |
| Q2 2021 | $2,728,000 | -17.7% | 20,793 | -4.4% | 0.00% | -25.0% |
| Q1 2021 | $3,316,000 | +52.5% | 21,754 | -0.5% | 0.00% | +33.3% |
| Q4 2020 | $2,175,000 | +4.8% | 21,866 | +0.4% | 0.00% | 0.0% |
| Q3 2020 | $2,075,000 | -14.7% | 21,771 | +0.1% | 0.00% | -25.0% |
| Q2 2020 | $2,433,000 | +28.6% | 21,751 | -16.4% | 0.00% | 0.0% |
| Q1 2020 | $1,892,000 | -30.6% | 26,018 | -0.5% | 0.00% | -20.0% |
| Q4 2019 | $2,727,000 | -5.1% | 26,147 | -9.4% | 0.01% | -16.7% |
| Q3 2019 | $2,874,000 | -14.4% | 28,875 | -1.8% | 0.01% | -14.3% |
| Q2 2019 | $3,357,000 | -16.6% | 29,410 | -8.2% | 0.01% | -12.5% |
| Q1 2019 | $4,027,000 | -9.4% | 32,031 | -2.2% | 0.01% | -20.0% |
| Q4 2018 | $4,443,000 | -49.4% | 32,744 | +2.3% | 0.01% | -41.2% |
| Q3 2018 | $8,785,000 | +32.4% | 32,005 | -0.0% | 0.02% | +21.4% |
| Q2 2018 | $6,633,000 | +28.6% | 32,017 | +2.6% | 0.01% | +27.3% |
| Q1 2018 | $5,156,000 | +16.5% | 31,219 | -3.4% | 0.01% | +22.2% |
| Q4 2017 | $4,425,000 | -0.9% | 32,314 | -1.5% | 0.01% | -10.0% |
| Q3 2017 | $4,465,000 | +1.4% | 32,795 | -9.6% | 0.01% | +11.1% |
| Q2 2017 | $4,404,000 | +10.8% | 36,280 | -3.4% | 0.01% | +12.5% |
| Q1 2017 | $3,974,000 | -0.6% | 37,546 | -4.6% | 0.01% | 0.0% |
| Q4 2016 | $3,998,000 | -2.9% | 39,346 | -2.5% | 0.01% | 0.0% |
| Q3 2016 | $4,118,000 | -13.8% | 40,346 | +0.7% | 0.01% | -20.0% |
| Q2 2016 | $4,776,000 | +19.7% | 40,046 | +7.4% | 0.01% | +11.1% |
| Q1 2016 | $3,991,000 | +13.1% | 37,272 | +14.5% | 0.01% | 0.0% |
| Q4 2015 | $3,529,000 | +28.6% | 32,553 | +1.6% | 0.01% | +28.6% |
| Q3 2015 | $2,744,000 | -15.1% | 32,038 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $3,233,000 | +16.3% | 32,038 | -11.1% | 0.01% | +14.3% |
| Q1 2015 | $2,779,000 | +35.8% | 36,044 | -6.2% | 0.01% | +40.0% |
| Q4 2014 | $2,046,000 | -10.5% | 38,444 | -20.9% | 0.01% | -16.7% |
| Q3 2014 | $2,285,000 | -3.1% | 48,630 | +28.4% | 0.01% | 0.0% |
| Q2 2014 | $2,358,000 | +8.3% | 37,863 | +17.0% | 0.01% | 0.0% |
| Q1 2014 | $2,177,000 | +28.3% | 32,363 | +0.3% | 0.01% | +20.0% |
| Q4 2013 | $1,697,000 | +22.3% | 32,263 | +0.6% | 0.01% | +25.0% |
| Q3 2013 | $1,388,000 | +19.4% | 32,063 | +3.3% | 0.00% | 0.0% |
| Q2 2013 | $1,162,000 | +44.0% | 31,044 | +2.5% | 0.00% | +33.3% |
| Q1 2013 | $807,000 | – | 30,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |